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A novel vector with high gene delivery eﬃciency and special cell-targeting ability was developed using a good strategy that
utilized low-molecular-weight polyethylenimine (PEI; molecular weight: 600 KDa [PEI600]) crosslinked to β-cyclodextrin (β-
CyD) via a facile synthetic route. Fibroblast growth factor receptors (FGFRs) are highly expressed in a variety of human cancer
cells and are potential targets for cancer therapy. In this paper, CY11 peptides, which have been proven to combine especially
with FGFRs on cell membranes were coupled to PEI-β-CyD using N-succinimidyl-3-(2-pyridyldithio) propionate as a linker. The
ratios of PEI600, β-CyD, and peptide were calculated based on proton integral values obtained from the 1H-NMR spectra of
the resulting products. Electron microscope observations showed that CY11-PEI-β-CyD can eﬃciently condense plasmid DNA
(pDNA) into nanoparticles of about 200nm, and MTT assays suggested the decreased toxicity of the polymer. Experiments on
gene delivery eﬃciency in vitro showed that CY11-PEI-β-CyD/pDNA polyplexes had signiﬁcantly greater transgene activities than
PEI-β-CyD/pDNA in the COS-7 and HepG2 cells, which positively expressed FGFR, whereas no such eﬀect was observed in the
PC-3 cells, which negatively expressed FGFR. Our current research indicated that the synthesized nonviral vector shows improved
gene delivery eﬃciency and targeting speciﬁcity in FGFR-positive cells.
1.Introduction
N u m e r o u sv e c t o r sh a v eb e e ne x p l o r e df o ru s ei ng e n ed e l i v -
ery. An ideal vector system eﬃciently uptakes and delivers
drugs to target cells without stimulating signiﬁcant immune
responses, inﬂammation reactions, or cytotoxicity [1].
Although viruses are known to facilitate the entry of pDNA
into cells, great concern about the safety and immuno-
genicity of viral vectors has made nonviral vectors a more
attractive option than viral ones. Thus, there is a growing
need to develop biocompatible polymeric gene carriers that
will not elicit immune responses and toxic side eﬀects [2, 3].
Among the nonviral vectors available, polyethylenimine
(PEI) has shown high gene delivery eﬃciency both in vitro
and in vivo [4]; as such, it has received signiﬁcant attention
as a research subject. PEI molecules consist of repeated
basic units with a backbone of two carbons followed by
one nitrogen atom and contain primary, secondary, and, in
the case of branched PEIs, tertiary amino groups, each of
which has the potential to be protonated [5, 6]. Positively
charged amino groups may interact with negatively charged
phosphate groups of DNA molecules to form polymer-DNA
polyplexes with sizes in the nanometer range that can be
internalized by cells [7]. β-CyD-modiﬁed polymers have
been shown to be able to stabilize cationic polymer/DNA
complexes under physiological conditions, increase water
solubility, show minimal cytotoxicity, and demonstrate good
transfection eﬃciencies in many cell lines [8]. In improving
the gene transfection eﬃciency of nonviral carriers, new
strategies have been put forward to enhance the cellu-
lar uptake of PEI-based polyplexes; modiﬁcation of the
polymer must be done [9], such that speciﬁc ligands can
be incorporated into the gene carriers. Several targeting
moieties,includingfolicacid,transferrin,RGDpeptide,HER2 Journal of Biomedicine and Biotechnology
peptide, EGF, and sugar moieties, have been employed in
polymeric gene carriers to enhance target cell speciﬁcity and
transfection eﬃciency.
Among these strategies, the ligand linkage strategy
appears to be the most attractive [7]. Receptor-meditated
gene delivery enhances the targeting ability and gene delivery
eﬃciency of PEI-β-CyD/pDNA polyplexes. However, when
ligands, especially those with high molecular weights, are
conjugated with PEI, the gene delivery eﬃciency of the
polyplexes may be aﬀected by a lower DNA condensation,
largerparticlesize,andincreasedspatialsterichindrance[10,
11]. Many functional peptides that speciﬁcally target tumors
were recently identiﬁed and applied as substitutes of whole
molecular ligands for the construction of targeting vectors to
overcome some disadvantages of nonviral polyplexes. In the
present study, a CY11 peptide-mediated nanopolymer was
prepared, its physicochemical properties were characterized,
and its transfection activities in FGF receptors (FGFRs)
overexpressing and under expressing cells were determined
[12]. The results indicated that FGFR-targeted polyplexes
had high gene eﬃciency and low cytotoxicity.
2.MaterialsandMethods
2.1. Chemicals and Reagents. PEI (branched 600KDa or PEI
25KDa), N-succinimidyl-3-(2-pyridyldithio) propionate
(SPDP, Molecular weight=312.4Da), 1-(4, 5-dimethylthia-
zol-2-yl)-3,5-diphenylformazan (MTT), dimethyl sulfoxide
(DMSO), and triethylamine (TEA) were obtained from
Sigma-Aldrich. The oligopeptide (CY11: CGMQLPLATWY)
was synthesized by GL Biochem (Shanghai, China), and
its amino acid sequence was conﬁrmed using mass
spectrography.1,1-Carbonyldiimidazole(CDI)wasobtained
fromPierce(Rockford,IL,USA).PlasmidpCAG-Luc-encod-
ing luciferase activity assay kits were obtained from Promega
(Madison, WI, USA). The plasmid pEGFP encoding green
ﬂuorescence protein (GFP) was provided by the Institute of
Immunology, Zhe Jiang university, Hangzhou, China.
COS-7 (FGFR positive; a continuous cell line derived
from an African green monkey kidney), HepG2 (FGFR
positive; a human hepatocellular cancer cell line), and
PC-3 (FGFR negative; a human prostate adenocarcinoma
cell line) were obtained from the American Type Culture
Collection (ATCC, Rockville, MD, USA). These cell lines
were maintained in RPMI1640 supplemented with 10% fetal
calf serum (FCS), 2mM glutamine, 100units/mL penicillin,
and 100μg/mL streptomycin in a 37◦C incubator with 5%
CO2.
2.2. Synthesis of PEI-β-CyD and CY11-PEI-β-CyD. PEI-β-
CyD was prepared according to the method of Tang et al.
[13].
SPDP (3.6mg, 0.01mmol) was dissolved in DMSO
(0.3mL),andPEI-β-CyD(120mg,0.65mmol)wasdissolved
in DMSO (3mL). The activation reaction proceeded under a
nitrogenatmosphereinthedarkfor1hatroomtemperature.
Peptide (12mg, 12.3μmol) was dissolved in 1 × PBS buﬀer
(1mL). The peptide solution was dropped slowly into
the SPDP-activated PEI-β-CyD solution under stirring at
room temperature under nitrogen for 3h. The product
was dialyzed against pure running water with a dialysis
membrane (molecular weight cutoﬀ=(8,000–14,000)) and
lyophilized for 48h. The ﬁnal product was stored at −80◦C.
2.3. 1H-Nuclear Magnetic Resonance (1H-NMR) Analysis.
The structures of CY11, PEI-β-CyD, and CY11-PEI-β-CyD
wereascertainedbystudyingtheir 1H-NMRspectra.Samples
(5mg) were dissolved in 0.7mL deuterium oxide (D2O).
The spectra were recorded using a Bruker 400MHz NMR
spectrometer with 32 scans at room temperature.
2.4. Agarose Gel Electrophoresis Assay. The electrophoretic
mobility of the polymer/pDNA polyplexes was measured
usingagelelectrophoresissystem.Anappropriateamountof
polymer was added to an equal volume of pDNA solution to
achieve the desired polymer/pDNA ratio. Gel electrophoresis
was conducted at room temperature in TEA buﬀer with 1%
(w/w) agarose gel at 100V for 45min. DNA bands were
visualized by an UV illuminator.
2.5. Electron Microscope Detection. Polyplexes of CY11-PEI-
β-CyD/pDNA at a N/P ratio of 25 were prepared in 0.9%
saline. After vortexing for 1min and standing for 30min,
the polyplexes were observed under a transmission electron
microscope (JEOL, JEM-2010 TEM, JPN).
2.6. Cell Viability Assay. COS-7, HepG2, and PC-3 cells
were grown in RPMI1640 supplemented with 10% FCS
at 37◦C and 5% CO2 in 96-well plates (Falcon; Becton
Dickinson, USA) at an initial density of 8,000cells/well to
10,000cells/well. The growth medium was replaced with
200μL serum-free RPMI1640 containing PEI 25 KDa,
PEI600, PEI-β-CyD, and CY11-PEI-β-CyD at diﬀerent
concentrations (5, 10, 20, 40, 80, 120, and 160nmol/mL).
After 4h of incubation, the medium was replaced with
200μL freshly grown medium; following another 24h of
incubation, the cells were washed once with PBS. Then
90μL fresh medium and 10μLM T Ts o l u t i o n( 5 m g / m L )
were added to each well. The plates were vigorously shaken
before measurement. Cell viability was assessed by obtaining
the absorbance of the products at 570nm as measured
by a BioRad microplate reader (Model 550, BioRad). Cell
growth (%) relative to the control cells cultured in the
media without PEI25KDa, PEI600, PEI-β-CyD, or CY11-
PEI-β-CyD was calculated using the following formula:
[A]test/[A]control ×100.
2.7. In Vitro Gene Delivery. COS-7, HepG2, and PC-3 cells
were used for gene delivery tests. The cells were seeded in
24-well plates at a density of 1.0 × 105/well with 0.6mL
RPMI1640 containing 10% FCS. After 24h of incuba-
tion, the culture media were replaced with 0.6mL serum-
free RPMI1640. Polyplexes of PEI600/PCAG-luc, PEI-β-
CyD/PCAG-luc, and CY11-PEI-β-CyD/PCAG-luc with dif-
ferent N/P ratios (20, 25, 30, 35, 40) containing 1μg
PCAG-luc were added to each well, where as polyplexes ofJournal of Biomedicine and Biotechnology 3
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Figure 1: 1H-NMR analysis of (a) CY11, (b) PEI-β-CyD, and (c)
CY11-PEI-β-CyD. The peaks at 2.5–3.2ppm are assigned to the
protons of PEI600 in (b) and (c). At 0.8–1.3 and 6.7–7.6ppm, the
new peaks are assigned to the protons of the amino acids of CY11
in (a) and (c).
PEI25KDa/PCAG-luc at an N/P ratio of 10 were included in
the control group. After a 4h of incubation, the medium was
removed and supplemented with fresh medium containing
10% FBS. Luciferase gene expression was determined 36h
after transfection using a commercial luciferase assay kit
(Promega, USA). The transfection eﬃciency was expressed
as relative light units per milligram of cell protein, the
concentration of which was determined using a protein assay
kit (BCA, Pierce, USA).
pEGFP plasmids were used to detect the green ﬂuo-
rescence emitted by green ﬂuorescence proteins after the
plasmidsweredeliveredtotheCOS-7,HepG2,andPC-3cells
at an N/P ratio of 25.
2.8. Statistical Analysis. Unless otherwise noted, the results
from in vitro experiments represent at least two independent
experiments. All results were expressed as means±standard
error of mean (SEM). Statistical analysis was performed
using one-way analysis of variance (ANOVA) and the LSD
test. Analysis was conducted using SPSS12.0.A mean with
P<0.05 considered statistically signiﬁcant.
3. Results
3.1. Synthesis and Characterization of CY11-PEI-β-CyD.
CY11-PEI-β-CyD synthesis was conducted according to
Tang et al. [13]. The 1H-NMR spectra of PEI-β-CyD
were obtained to determine the ratio of PEI600 and β-
CyD (Figure 1(b)). The stoichiometry between PEI600 and
β-CyD was calculated using the characteristic peaks of
PEI600 (–CH2CH2NH–) and the C-1 hydrogen in β-CyD.
In our experiment, the molar ratio of PEI600 and β-CyD
was approximately 1:1.2.
The CY11 with a single cysteine at the end was directly
coupled onto the SPDP-activated PEI-β-CyD to produce the
CY11-PEI-β-CyD. The successful synthesis of CY11-PEI-β-
CyD was conﬁrmed using 1H-NMR spectra, as shown in
Figure 1(c). The characteristic peaks of PEI (–NHCH2CH2–)
appeared at δ2.5ppm to 3.3ppm, those of β-CyD appeared
at δ5.0ppm and δ3.4ppm to 4.0ppm, and those of the CY11
peptide appeared at δ0.8ppm to 1.3ppm and 6.7ppm to
7.6ppm (–CH2–protons of peptide) of CY11-PEI-β-CyD.
These ﬁndings suggest the successful conjugation of CY11 to
PEI-β-CyD.
3.2. Complex Formation of CY11-PEI-β-CyD/DNA. The
binding capability of PEI-β-CyD and CY11-PEI-β-CyD
to DNA was evaluated using agarose gel electrophoresis
(Figure 2), and CY11-PEI-β-CyD was found to stably form
an N/P ratio of 4 (Figure 2(b)). However, the ability to
binding DNA was delayed, which was likely caused by the
steric hindrance of the conjugated peptides. Comparison
of PEI-β-CyD with condensed DNA at an N/P ratio of
3( Figure 2(a)) showed that the peptide converted the
PEI primary amine into an amide, but the eﬃciency of
modiﬁcation was very low (<5% of the primary amines
modiﬁed).
The particle size of the copolymer/DNA complexes is
an important factor that aﬀects transfection activity. The
morphology of the CY11-PEI-β-CyD/DNA complex was
observed under TEM (Figure 3) .T h ep a r t i c l es i z eo ft h e
complexesatanN/Pratioof25/1wasapproximately200nm,
which was a suitable diameter for gene delivery.
3.3. Toxicity Assay of Copolymer. MTT assays of the COS-
7, HepG2, and PC-3 cells were performed to evaluate the
cytotoxicity of PEI600, PEI-β-CyD, CY11-PEI-β-CyD, and
PEI25KDaoveranincubationperiodof4hatconcentrations
ranging from 0 to 160nmol/mL, as shown in Figure 4.I n
the present study, CY11-PEI-β-CyD showed low toxicity
against the COS-7, HepG2, and PC-3 cell lines compared
withthecontrolgroup(PEI25KDa).Whentheconcentration
was over 120nmol/mL, the percentage of cell viability
remained above 60%. A very sharp drop in the number of
viable cells was observed for PEI25KDa with increasing the
concentration. Furthermore, the modiﬁcation of PEI with β-
CyD led to a reduction in toxic side eﬀects in vitro.
3.4. Gene Transfer In Vitro. In verifying the enhanced gene
delivery ability of CY11-PEI-β-CyD and the targeting ability
of the CY11 motif, gene delivery experiments in vitro
were conducted in COS-7 (FGFR-positive), HepG2 (FGFR-
positive), and PC-3 (FGFR-negative) cells using plasmid
pCAG-Luc. The transfection eﬃciency of the CY11-PEI-
β-CyD/DNA complex in the COS-7 cells is shown in
Figure 5(a). The data demonstrated that the transfection
eﬃciency of CY11-PEI-β-CyD was twofold higher than
that of PEI-β-CyD at an N/P ratio of 25 achieved at
4.13 × 1010 RLU/mg protein. Similarly, an improvement
in transfection eﬃciency was observed with CY11-PEI-β-
CyD in HepG2 cells (Figure 5(b)). By contrast, in PC3 cells4 Journal of Biomedicine and Biotechnology
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Figure 2: Agarose gel electrophoresis of 0.5μgD N Ac o m p l e x e dw i t h( a )P E I - β-CyD and (b) CY11-PEI-β-CyD at N/P ratios from 1 to 7.
300 nm
Figure 3: Transmission electron micrograph of the CY11-PEI-β-
CyD/DNA polyplex. The polyplex is spherical with a diameter of
about 200nm.
(Figure 5(c)) and at an N/P ratio of 20, the eﬃciency of PEI-
β-CyD was about one and a half-fold higher than that of
CY11-PEI-β-CyD. Even at other N/P ratios, including 25, 30,
35, and 40, the eﬃciency of PEI-β-CyD was higher than that
of CY11-PEI-β-CyD. “Gold standard” branched PEI25KDa
exhibited the highest gene expression at N/P ratio of 10 and
decreased with higher N/P [13]. PEI-β-CyD and CY11-PEI-
β-CyD complexes showed higher transfection eﬃciency at
N/P ratios of 20, 25, and 30 than PEI25KDa complex at its
optimal N/P of 10.
In order to further study the gene delivery capability
of CY11-PEI-β-CyD, pEGFP plasmids were transferred to
the COS-7, HepG2, and PC-3 cells to enable the direct
observation of green ﬂuorescence under a ﬂuorescence
microscope (Figures 5(d), 5(e) and 5(f)). The transfer
eﬃciency was far higher in COS-7 and HepG2 cells than in
PC-3 cells. In summary, the transfection study demonstrated
that CY-11 peptide-mediated PEI-β-CyD vectors could oﬀer
a strategy for targeted gene delivery, especially for FGFR
highly expressing tumor cells.
4. Discussion
T h eg e n ed e l i v e r ya b i l i t yo fP E Iw a sﬁ r s td i s c o v e r e db y
Boussif et al. in 1995 [14]. Since then, the mechanism has
been extensively explored, and many strategies have been
undertaken in attempts to improve its eﬃciency of PEI.
PEI is widely used as a nonviral gene transfer vector. In
the ﬁeld of biomedical science, PEI could be an eﬀective
gene delivery vector for in vitro and in vivo transfection.
However, like other general nonviral vectors [15], PEI
shows low gene delivery eﬃciency and high cytotoxicity
compared with viral vectors. One of the strategies that
may be used to improve the eﬃciency of PEI is to modify
PEI with ligands that target speciﬁc receptors on cell
membranes [16]. Many peptides function as ligands for
targeted nonviral gene delivery systems to speciﬁc cell and/or
tissue types within the body and enhance the delivery
of nonviral vectors. EGF, folate, Her-2, transferring, and
antibodies are commonly used as such ligands, but obtain-
ing, identifying, and isolating these ligands are complicated
and tedious [12]. More importantly, the combination of
ligands, especially those with high molecular weights, may
potentially aﬀect the biological behavior of the vector
and decrease gene delivery eﬃciency due to steric aﬀects
[7].
FGFRs are highly expressed in many tumor cells and
are upregulated in proliferating endothelial cells during
angiogenesis [17]. They can improve gene delivery by
overcoming identiﬁed cellular barriers and targets for cancer
gene therapy. Maruta et al. [12] found that the oligopeptide
CY11 binds to FGFR receptors with high aﬃnity via a novel
phage display technology and veriﬁed the occurrence of
enhanced gene expression using polylysine-based complexes
with the oligopeptides.
In the present study, the oligopeptide CY11 was selected
to conjugate with PEI-β-CyD, and the chemical and biolog-
ical characteristics of the resulting CY11-PEI-β-CyD/pDNA
polyplexes were investigated. PEI-β-CyD has an abundance
of amine groups, much higher than the number of sulfhydryl
groups in CY11, such that the complete conjugation of
CY11 with PEI-β-CyD is possible. The molar ratio of
CY11 to PEI-β-CyD in the CY11-PEI-β-CyD complex
equaled that found in theoretical calculations from 1H-NMR
results.
DNAcondensation,particlesize,andtoxicityofthepoly-
plexes are closely related to delivery eﬃciency [18]. Ideally,
polyplexes should be homogeneous, soluble, stable, small,Journal of Biomedicine and Biotechnology 5
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Figure 4: The cytotoxicity of PEI600, PEI-β-CyD, CY11-PEI-β-CyD, and PEI25KDa against (a) COS-7, (b) HepG2, and (c) PC-3 cells. The
cells were treated with polymer of diﬀerent concentrations for 4h in a serum-containing medium. Cell viability was determined using MTT
assays and expressed as percentages of the control. When the concentration of the polymer was <20nmol/mL, the toxicities of the polymers
were similar (P>0.05).
and have low toxicity. Gel retardation assay results showed
that, after conjugation of CY11, the ability of PEI-β-CyD for
pDNA condensation decreased, signifying that the surface
charges of PEI-β-CyD were blocked by CY11. The cells
toxicity assay conﬁrmed this result and showed that, even at
a CY11-PEI-β-CyD concentration of 120nmol/mL, the per-
centage of cell viability remained above 60%. The cytotoxic-
ity of PEI was related to the positively charged amine groups,
so PEI25KDa was found to have high toxicity. CY11 itself
did not stimulate the growth of cells. Spherical polyplexes of
about 200nm in diameter were found to be suitable for gene
delivery.
In examining the role of CY11 oligopeptides, FGFRs
were highly expressed on COS-7 and HepG2 cells and lowly
expressed on PC-3 cell surfaces. The eﬃciency of CY11-
PEI-β-CyD (25:1) in COS-7 (25:1) and HepG2 cells was
about twofold higher than that of the PEI-β-CyD group
and higher than that of PEI25KDa (10:1) at a suitable N/P
ratio. Based on the in vitro results obtained from COS-7
cells, although not very obvious, the eﬃciency of CY11-PEI-
β-CyD (25:1) was found to be higher than that of CY11-
PEI-β-CyD polymers with other conjugation ratios, such as
20:1, 30:1, 35:1, and 40:1. An optimal conjugation ratio
of oligopeptides is thus suggested to be present in this type
of molecules. Toolow or toohigh conjugation ratios of CY11
may aﬀect the eﬃciency observed because of insuﬃcient
ligand-mediated actions or steric hindrance eﬀects. The
decreased eﬃciency of CY11-PEI-β-CyD in PC-3 cells indi-
cated that FGFR mediated the enhanced transgene activity
of CY11-PEI-β-CyD. The pathway of polyplex binding to
cells is a receptor-mediated process and not a simple static
electricity one; thus, an enhancement in eﬃciency could
be expected [12]. By contrast, for receptor-negative cells,
conjugation of the corresponding ligands yielded no beneﬁts
for achieving eﬃciency. Considering the high expression of
FGFR in most tumor cells, the observed enhancement in
eﬃciency indicated that CY11-PEI-β-CyD could be used
in future applications as a delivery vector for cancer gene
therapy.6 Journal of Biomedicine and Biotechnology
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Figure 5 :T h eg e n ed e l i v e r ye ﬃciencies of PEI600, PEI-β-CyD, CY11-PEI-β-CyD, and PEI25KDa with diﬀerent N/P ratios in (a) COS-7,
(b) HepG2, and (c) PC-3 cells. PEI25KDa at an N/P ratio of 10 shows the highest gene delivery eﬃciency. Data were shown as mean±SD,
(∗P<0.05 as compared with other samples in the same group). The green ﬂuorescence emitted by green proteins expressed after the
transfer of CY11-PEI-β-CyD/pEGFP at an N/P ratio of 25 to cells: (d) COS-7, (e) HepG2, and (f) PC-3 cells. A ﬂuorescence microscope is
used. Fluorescence is more evident in COS-7 (FGFR-positive) and HepG2 (FGFR-positive) cells than in PC-3 (FGFR-negative) ones.Journal of Biomedicine and Biotechnology 7
In summary, the successfully synthesized CY11-PEI-β-
CyD polymer can eﬃciently condense DNA plasmids into
spherical particles of about 200nm in diameter and with
positive zeta potential. The polymer has less cytotoxicity and
more eﬃcient gene delivery capabilities than PEI-β-CyD in
vitro. It also has FGFR-targeting ability.
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